{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:19:43Z","timestamp":1792189183448,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cmi.2024.12.024","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:07:02Z","timestamp":1735258022000},"page":"713-723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparative efficacy and safety of treatment regimens for Pneumocystis jirovecii pneumonia in people living with HIV: a systematic review and network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"31","author":[{"given":"Stefan","family":"Hatzl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Posch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kriegl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Kreuzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Eller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele Roberto","family":"Giacobbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hoenigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2024.12.024_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1128\/cmr.00101-22","article-title":"Pneumocystis jirovecii pneumonia in people living with HIV: a review","volume":"37","author":"McDonald","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2024.12.024_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab545","article-title":"On the treatment of Pneumocystis jirovecii pneumonia: current practice based on outdated evidence","volume":"8","author":"McDonald","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2024.12.024_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jama.2023.9844","article-title":"Prophylaxis against Pneumocystis jirovecii pneumonia in adults","volume":"330","author":"Zhou","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2024.12.024_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00002030-200301030-00010","article-title":"Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia","volume":"17","author":"Morris","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2024.12.024_bib5","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/infdis\/jiw085","article-title":"Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010","volume":"214","author":"Buchacz","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2024.12.024_bib6","series-title":"Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV","year":"2019"},{"key":"10.1016\/j.cmi.2024.12.024_bib7","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/hiv.13542","article-title":"Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023","volume":"24","author":"Ambrosioni","year":"2023","journal-title":"HIV Med"},{"key":"10.1016\/j.cmi.2024.12.024_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/cmr.00074-23","article-title":"Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease","volume":"37","author":"Hoenigl","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2024.12.024_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archinte.1996.00440020081010","article-title":"A\u00a0meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens","volume":"156","author":"Ioannidis","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cmi.2024.12.024_bib10","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1503\/cmaj.111152","article-title":"Considerations when prescribing trimethoprim-sulfamethoxazole","volume":"183","author":"Ho","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.cmi.2024.12.024_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2024.12.024_bib12","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.12.024_bib13","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.cmi.2024.12.024_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.cmi.2024.12.024_bib15","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM199604183341602","article-title":"Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group","volume":"334","author":"Collier","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2024.12.024_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1536867X1101100206","article-title":"Multivariate random-effects meta-regression: updates to mvmeta","volume":"11","author":"White","year":"2011","journal-title":"Stata J"},{"key":"10.1016\/j.cmi.2024.12.024_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2024.12.024_bib18","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2017047","article-title":"Network meta-analysis: application and practice using Stata","volume":"39","author":"Shim","year":"2017","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.cmi.2024.12.024_bib19","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.cmi.2024.12.024_bib20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1086\/514696","article-title":"Clindamycin with primaquine vs. trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group","volume":"27","author":"Toma","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.12.024_bib21","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/0003-4819-124-9-199605010-00003","volume":"124","author":"Safrin","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2024.12.024_bib22","first-page":"1068","article-title":"Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immune deficiency syndrome","volume":"151","author":"Montgomery","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2024.12.024_bib23","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/infdis\/170.4.912","article-title":"Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death","volume":"170","author":"Safrin","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2024.12.024_bib24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.7326\/0003-4819-121-3-199408010-00003","article-title":"Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group","volume":"121","author":"Dohn","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2024.12.024_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/infdis\/170.1.165","volume":"170","author":"Sattler","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2024.12.024_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF03257446","article-title":"Pentamidine aerosol vs cotrimoxazole in the treatment of slight to moderate pneumocystis carinii pneumonia","volume":"8","author":"Arast\u00e9h","year":"1994","journal-title":"Drug Investig"},{"key":"10.1016\/j.cmi.2024.12.024_bib27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/clinids\/17.2.178","article-title":"Clindamycin\/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind pilot trial","volume":"17","author":"Toma","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.12.024_bib28","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJM199305273282103","article-title":"Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS","volume":"328","author":"Hughes","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2024.12.024_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00002030-199203000-00007","article-title":"Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial","volume":"6","author":"Klein","year":"1992","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2024.12.024_bib30","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJM199009203231202","article-title":"Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone","volume":"323","author":"Medina","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2024.12.024_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7326\/0003-4819-113-3-203","article-title":"Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial","volume":"113","author":"Conte","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2024.12.024_bib32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/0003-4819-113-3-195","article-title":"Inhaled or intravenous pentamidine therapy for Pneumocystis carinii pneumonia in AIDS. A randomized trial","volume":"113","author":"Soo Hoo","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2024.12.024_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-105-1-37","article-title":"Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial","volume":"105","author":"Wharton","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2024.12.024_bib34","first-page":"CD006150","article-title":"Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection","volume":"2015","author":"Ewald","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2024.12.024_bib35","first-page":"866","article-title":"Comparative efficacy and safety of Pneumocystis jirovecii pneumonia prophylaxis regimens for people living with HIV: a systematic review and network meta-analysis of randomized controlled trials","volume":"30","author":"Prosty","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.12.024_bib36","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.12.024_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201733","article-title":"Outcomes of HIV-associated pneumocystis pneumonia at a South African referral hospital","volume":"13","author":"Chiliza","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2024.12.024_bib38","doi-asserted-by":"crossref","first-page":"323.","DOI":"10.1186\/s13054-023-04608-1","article-title":"Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG","volume":"27","author":"Giacobbe","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2024.12.024_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1164\/rccm.202311-2011ST","article-title":"An update on management of adult patients with acute respiratory distress syndrome: an official American Thoracic Society clinical practice guideline","volume":"209","author":"Qadir","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2024.12.024_bib40","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/infdis\/jiab460","article-title":"Epidemiology and clinical impact of respiratory coinfections at diagnosis of Pneumocystis jirovecii pneumonia","volume":"225","author":"L\u00e9cuyer","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2024.12.024_bib41","first-page":"47","article-title":"Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole","volume":"112","author":"Hughes","year":"1975","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.cmi.2024.12.024_bib42","doi-asserted-by":"crossref","first-page":"ofaa449","DOI":"10.1093\/ofid\/ofaa449","article-title":"Clinical trials increase off-study drug use: a segmented time-series analysis","volume":"7","author":"Butler-Laporte","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2024.12.024_bib43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00043764-199604000-00004","article-title":"Reactive airways dysfunction syndrome in a nurse exposed to pentamidine","volume":"38","author":"Stanbury","year":"1996","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.cmi.2024.12.024_bib44","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0140-6736(89)91898-9","article-title":"Aerosolised pentamidine","volume":"2","author":"Thomas","year":"1989","journal-title":"Lancet"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24006128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24006128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T01:29:44Z","timestamp":1744421384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X24006128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1198743X24006128"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2024.12.024","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy and safety of treatment regimens for Pneumocystis jirovecii pneumonia in people living with HIV: a systematic review and network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2024.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}